ARTICLE SUMMARY:
Sales and placements of surgical robotic systems took a near-term hit during the early days of the pandemic, but the rebound has been surprisingly strong, and companies continue to invest in the field aggressively.
In the noisy environment surrounding pandemic-driven market data, sorting out financially stressed hospitals’ appetite for investing in expensive technologies is tough.
